Nexpoint Asset Management’s Medicines Co MDCO Stock Holding History

Nexpoint Asset Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-23,900	Closed	-$2.03M	–	327
2019 Q4	$2.03M	Buy	+23,900	New	+$1.59M	0.15%	85

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Nexpoint Asset Management's MDCO Position: Q1 2020 in Review

Nexpoint Asset Management sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 23,900 shares — an estimated $2.03M sold.

Nexpoint Asset Management first reported a position in MDCO in Q4 2019 and held it in 1 quarter. The position peaked at $2.03M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Nexpoint Asset Management reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Nexpoint Asset Management sold 23,900 Medicines Co shares in Q1 2020, an estimated $2.03M.
Nexpoint Asset Management first reported a position in Medicines Co in Q4 2019 and held it in 1 quarter.
Nexpoint Asset Management's Medicines Co position peaked at $2.03M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Nexpoint Asset Management's 13F filing for Q1 2020, filed 15 May 2020.